China Universal Asset Management Company’s Definium Therapeutics DFTX Stock Holding History

China Universal Asset Management Company’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1M	Buy	21,358 +1,166	+6%	+$28.8K	0.06%	204
2026 Q1	$382K	Buy	20,192 +4,140	+26%	+$70.3K	0.03%	285
2025 Q4	$215K	Buy	16,052 +2,715	+20%	+$33.6K	0.02%	339
2025 Q3	$157K	Sell	13,337 -1,838	-12%	-$17.1K	0.01%	349
2025 Q2	$98.5K	Buy	15,175 +466	+3%	+$3.06K	0.01%	369
2025 Q1	$86K	Sell	14,709 -840	-5%	-$6.02K	0.01%	369
2024 Q4	$108K	Buy	+15,549	New	+$107K	0.01%	382

Other funds holding DFTX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return

China Universal Asset Management Company's DFTX Position: Q2 2026 in Review

China Universal Asset Management Company increased its Definium Therapeutics (DFTX) stake by 5.8% in Q2 2026, buying an estimated $28.8K and bringing the position to 21,358 shares worth $1M. The position accounts for 0.06% of the portfolio, ranked #204.

China Universal Asset Management Company first reported a position in DFTX in Q4 2024 and has held it in 7 quarters since. 188 funds tracked by Wall St. Rank hold DFTX as of Q2 2026.

China Universal Asset Management Company held 21,358 shares of Definium Therapeutics worth $1M as of Q2 2026.
China Universal Asset Management Company bought 1,166 Definium Therapeutics shares in Q2 2026, an estimated $28.8K.
Definium Therapeutics made up 0.06% of China Universal Asset Management Company's portfolio in Q2 2026, its #204 holding.
China Universal Asset Management Company first reported a position in Definium Therapeutics in Q4 2024 and has held it in 7 quarters since.
188 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.